DAST-10 Drug Screening Calculator

The Drug Abuse Screening Test (DAST-10) is a highly efficient, 10-item clinical screening instrument engineered to identify and classify risks associated with non-medical drug consumption. Originally developed in 1982 by Dr. Harvey Skinner at the Addiction Research Foundation in Toronto, Canada, this condensed metric was extracted from a comprehensive 28-item framework. By isolating the data points with the highest statistical correlation to clinical substance dependence, the DAST-10 delivers an exceptionally reliable, low-friction assessment tool. It is widely utilized by occupational health professionals, human resource executives, and corporate risk managers to safeguard workplace safety and optimize Employee Assistance Program (EAP) workflows. From an operational standpoint, the DAST-10 evaluates behavioral patterns, psychological indicators, and physical consequences over a trailing 12-month window. The tool is strictly designed to analyze illicit drug use and the non-medical misuse of prescription medications, intentionally omitting alcohol consumption, which is tracked separately via metrics like the AUDIT. The scoring matrix is binary, assigning either 0 or 1 point per question. Crucially, Item 3 ('Are you always able to stop using drugs when you want to?') is reverse-scored to capture loss of behavioral control. The final score, ranging from 0 to 10, categorizes the respondent into distinct risk tiers that dictate corporate and clinical intervention protocols. In the corporate sector, substance abuse represents a massive financial drain, manifesting as absenteeism, workplace accidents, elevated healthcare premiums, and diminished productivity. The DAST-10 serves as an objective, evidence-based gatekeeper. It is endorsed by the Substance Abuse and Mental Health Services Administration (SAMHSA) as a core component of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) framework. By integrating this calculator into periodic health assessments, post-incident investigations, or return-to-work evaluations, enterprises can make data-driven decisions that balance employee welfare with organizational liability mitigation.

Calkulon makes complex calculations simple — built for students and everyday problem-solvers.

1. 1Establish a Secure and Compliant Screening Protocol: Administer the screening within a confidential, professional setting that complies with corporate policy, HIPAA, or local employment privacy laws. Explain to the individual that the assessment evaluates non-medical drug and prescription medication use over the past 12 months, and that alcohol and tobacco are excluded. Emphasize that honest disclosures are critical for accurate wellness planning and safety-sensitive role placements.
2. 2Collect the 10 Binary Risk Indicators: Present the 10 standardized yes/no questions. These questions evaluate key risk domains: initial non-medical use, polysubstance patterns, self-control capabilities, cognitive disruptions, emotional distress, interpersonal friction, operational neglect, illegal acquisition behaviors, physical dependency/withdrawal, and systemic medical complications. Digital self-administration is highly recommended to minimize social desirability bias and increase reporting accuracy.
3. 3Execute the Reverse-Scoring Calculation: Apply standard binary scoring (Yes = 1, No = 0) to items 1, 2, and 4 through 10. For Item 3 ('Are you always able to stop using drugs when you want to?'), apply reverse-scoring rules: a 'No' response indicates a failure of self-control and is scored as 1 point, while a 'Yes' indicates preserved control and is scored as 0 points. This step is critical, as scoring errors here frequently skew the final risk classification.
4. 4Aggregate and Determine the Risk Category: Sum the points across all 10 items to calculate the final score (range 0-10). Map this score to the standardized risk tiers: a score of 0 represents no reported issues; 1-2 indicates low risk; 3-5 represents moderate risk; 6-8 indicates substantial risk; and 9-10 signifies severe risk. Each tier corresponds to a specific clinical and corporate risk-mitigation pathway.
5. 5Trigger the Corresponding Corporate or EAP Response: For low-risk scores (1-2), provide educational materials and schedule routine annual monitoring. For moderate scores (3-5), mandate an EAP consult for a targeted behavioral intervention. For substantial (6-8) or severe (9-10) scores, temporarily restrict the employee from safety-sensitive operations and initiate a formal clinical assessment for a structured rehabilitation and return-to-work program.
6. 6Conduct Substance-Specific Hazard Analysis: Because the DAST-10 is substance-agnostic, positive screens must be followed by a targeted inquiry to identify the specific substances involved (e.g., synthetic opioids, stimulants, cannabis, or benzodiazepines). The pharmacological profile of the substance dictates the risk level for safety-sensitive roles, the necessary length of temporary suspension, and the medical protocol required for safe clearance.
7. 7Document Outcomes and Integrate with Risk Management: Record the DAST-10 score securely within the employee's confidential occupational health file, separate from general HR personnel records to ensure legal compliance. Integrate these metrics into broader corporate safety audits and wellness program performance reports. Utilize aggregated, anonymized screening data to justify wellness budgets and evaluate EAP partner performance over time.

• !Failing to Reverse-Score Item 3 (The Control Metric): The most frequent scoring error occurs when administrators treat Item 3 ('Are you always able to stop using drugs when you want to?') like the other questions. A 'No' on this item indicates a loss of control and must be scored as 1 point, whereas a 'Yes' is scored as 0 points. Treating a 'No' as 0 artificially lowers the risk score, potentially misclassifying a high-liability employee as low-risk.
• !Polluting the Assessment with Alcohol Consumption Data: Employees and HR managers often mistakenly include alcohol use when answering the DAST-10 questions. Because alcohol has distinct legal, metabolic, and clinical parameters, including it in this calculation distorts the data. Organizations must ensure that alcohol risk is evaluated exclusively through the AUDIT tool to preserve the validity of both risk profiles.
• !Using the Screening Tool as a Diagnostic or Punitive Instrument: The DAST-10 is a rapid risk-stratification screen, not a formal medical diagnosis or a legal justification for immediate termination. Using a high score as a blunt disciplinary instrument, rather than a gateway for professional clinical evaluation and EAP support, exposes an organization to significant legal liabilities, wrongful termination claims, and ADA violations.